Structure-Activity Relationships and Drug Design
Data Validation
Quantitative Aspects of Drug-Receptor Interaction
Protein-Drug Binding: Determination Methods
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Pharmacokinetic Models: Comparison and Selection Criterion
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 29, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1Plasma Chemistry Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Institute of Excellence of the Hungarian Academy of Sciences, Budapest, Hungary.
Model validation methods often yield contradictory results. The sum of absolute ranking differences (SRD) multicriteria analysis helps select optimal validation techniques and determine the applicability domain (AD) for better predictive performance.
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: